Clinical Trial Update: SOIBD Collagenous Colitis Maintenance Study [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating SOIBD for induction and maintenance of remission in collagenous colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Collagenous Colitis

Drugs mentioned

• SOIBD

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Induction and Maintaining Remission of Collagenous Colitis | Phase 3 | Status: COMPLETED